{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:04:25Z","timestamp":1789653865346,"version":"4.0.0"},"reference-count":246,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread chronic liver disease that can progress from steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Its pathogenesis involves lipotoxicity, iron metabolism disorders, and oxidative stress\u2014the same three processes that underlie ferroptosis, an iron-dependent form of regulated cell death mediated by the peroxidation of membrane phospholipids. However, the question of whether ferroptosis is a universal mechanism underlying the progression of MASLD as a whole or a hallmark of a distinct subgroup of patients remains unresolved. Furthermore, no ferroptosis-targeted strategy has yet been tested in a biomarker-selected population. This review addresses precisely this gap. Clinical, transcriptomic, and experimental data allow us to conceptualize hepatic ferroptosis as four interacting molecular modules: expansion of the labile pool of ferrous iron, enrichment of membranes with oxidizable polyunsaturated phospholipids, enzymatic and non-enzymatic lipid peroxidation, and failure of antioxidant defense. An imbalance in these modules leads to the accumulation of phospholipid hydroperoxides, disruption of membrane integrity, and immunogenic hepatocyte death with the release of signals that promote inflammation and fibrogenesis. At the same time, ferroptosis exhibits pronounced cellular and contextual specificity. It exerts a damaging effect on hepatocytes and sinusoidal endothelial cells, enhances inflammation in macrophages, but exerts an antifibrotic effect in activated stellate cells and immunosuppressive effects in lymphocytes. In this regard, known anti-ferroptotic strategies (iron chelation, inhibition of long-chain acyl-coenzyme A (CoA) synthase 4 (ACSL4)-dependent incorporation of polyunsaturated fatty acids, use of lipid radical scavengers and vitamin E, and activation of protective antioxidant programs) retain their diagnostic and therapeutic potential only within the framework of a molecularly and cell-stratified approach.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1912709","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:30:36Z","timestamp":1789651836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Stanislav","family":"Kotlyarov","sequence":"first","affiliation":[{"name":"Department of Nursing, Ryazan State Medical University","place":["Ryazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Iskrina","sequence":"additional","affiliation":[{"name":"Department of Nursing, Ryazan State Medical University","place":["Ryazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kotlyarova","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Pharmacy Practice Administration, Ryazan State Medical University","place":["Ryazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s40001-025-03151-9","article-title":"Stratified cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): impact of varying metabolic risk factor burden","volume":"30","author":"Elsabaawy","year":"2025","journal-title":"Eur J Med Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1618275","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes","volume":"12","author":"Dua","year":"2025","journal-title":"Front Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70132","article-title":"Metabolic dysfunction\u2010associated steatotic liver disease (MASLD): mechanisms, clinical implications and therapeutic advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311275","article-title":"Cardiovascular disease in the context of metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive narrative review","volume":"26","author":"Mustafa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27021066","article-title":"The interplay between cellular senescence and lipid metabolism in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"27","author":"Mastoridou","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2025.100526","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"25","author":"Hsu","year":"2025","journal-title":"Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14248872","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): new perspectives on an evolving epidemic","volume":"14","author":"Lake-Bakaar","year":"2025","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications","volume":"49","author":"Truong","year":"2025","journal-title":"Diabetes Metab J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13564","article-title":"Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus","volume":"16","author":"Han","year":"2024","journal-title":"J Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103513","article-title":"Exploring the prevalence and risk factors of MASLD in patients with newly diagnosed diabetes mellitus: a comprehensive investigation","volume":"14","author":"Beyazal Polat","year":"2025","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"B17","unstructured":"Metabolic dysfunction-associated steatotic liver disease (MASLD)\n          \n          \n            \n              Girish\n              V\n            \n            \n              John\n              S\n            \n          \n          StatPearls Publishing\n          Statpearls [Internet]\n          \n          2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(26)00011-7","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 1990\u20132023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"11","author":"Kim","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2024.00019","article-title":"Mechanism of metabolic dysfunction-associated steatotic liver disease: important role of lipid metabolism","volume":"12","author":"Feng","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2025.1001365","article-title":"The transition from NAFLD to MASLD: implications for diagnosis, prognosis, and clinical management","volume":"6","author":"Acierno","year":"2025","journal-title":"Explor Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2023","journal-title":"J Lipid Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-025-02599-w","article-title":"Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases","volume":"103","author":"Liu","year":"2025","journal-title":"J Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105088","article-title":"Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation","volume":"102","author":"Peleman","year":"2024","journal-title":"eBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1286449","article-title":"Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01348-9","article-title":"Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Peleman","year":"2024","journal-title":"Cell Death Differ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000828","article-title":"Metabolic dysfunction and alcohol-associated liver disease: a narrative review","volume":"16","author":"Dunn","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2025-100319","article-title":"Metabolic dysfunction and alcohol-associated liver disease (MetALD)","volume":"3","author":"Gao","year":"2025","journal-title":"egastro"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217553","article-title":"Sedentary behavior as a risk factor for liver fibrosis development in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cross-sectional study","volume":"14","author":"Bianco","year":"2025","journal-title":"JCM"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1853319","article-title":"Prospective association between biological aging and risk of hospital-diagnosed MASLD: evidence from the UK Biobank","volume":"17","author":"Yang","year":"2026","journal-title":"Front Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15070830","article-title":"Mitochondrial quality control in age-related diseases: from molecular architecture to precision therapeutics","volume":"15","author":"Che","year":"2026","journal-title":"Antioxidants"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13080906","article-title":"Altered mitochondrial function in MASLD: key features and promising therapeutic approaches","volume":"13","author":"Radosavljevic","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202503607RR","article-title":"The gut\u2010liver axis in metabolic dysfunction\u2010associated steatotic liver disease: from mechanistic insights to precision therapeutics","volume":"40","author":"Zhu","year":"2026","journal-title":"FASEB J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.76865","article-title":"Gut\u2010liver translocation of Bacteroides Uniformis alleviates advanced metabolic dysfunction\u2010associated steatotic liver disease by suppressing hepatocyte ferroptosis via propionic acid secretion","author":"Liu","year":"2026","journal-title":"Adv Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101185","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.119053","article-title":"Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"400","author":"Iturbe-Rey","year":"2025","journal-title":"Atherosclerosis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.08.007","article-title":"The role of endoplasmic reticulum in lipotoxicity during metabolic dysfunction\u2013associated steatotic liver disease (MASLD) pathogenesis","volume":"193","author":"Venkatesan","year":"2023","journal-title":"Am J Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1718799","article-title":"Restoring metabolic flexibility: targeting organelle interaction networks in the pathogenesis and therapy of MASLD","volume":"13","author":"Liu","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.iliver.2025.100195","article-title":"Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage","volume":"4","author":"Gou","year":"2025","journal-title":"iLIVER"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040476","article-title":"Innate immunity and MASLD","volume":"14","author":"Meyer","year":"2024","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101414","article-title":"Inflammation in MASLD progression and cancer","volume":"7","author":"Kim","year":"2025","journal-title":"JHEP Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s44324-025-00083-0","article-title":"Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies","volume":"3","author":"Raza","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062394","article-title":"A comprehensive review of metabolic dysfunction-associated steatotic liver disease: Its mechanistic development focusing on methylglyoxal and counterbalancing treatment strategies","volume":"26","author":"Berdowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1639064","article-title":"Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: An integrative perspective from molecular pathways to clinical challenges","volume":"16","author":"Ma","year":"2025","journal-title":"Front Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24236","article-title":"Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes","volume":"33","author":"Qu","year":"2025","journal-title":"Obesity"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14121411","article-title":"Ferroptosis in human diseases: Fundamental roles and emerging therapeutic perspectives","volume":"14","author":"Artusi","year":"2025","journal-title":"Antioxidants"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202524387","article-title":"Ferroptosis: The demise of cells through phospholipid peroxidation","volume":"13","author":"Cui","year":"2026","journal-title":"Adv Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol BioMed"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.03.013","article-title":"The chemistry and biology of ferroptosis","volume":"27","author":"Stockwell","year":"2020","journal-title":"Cell Chem Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"202512","DOI":"10.70401\/fos.2026.0015","article-title":"Fundamental mechanism of ferroptosis: Three unanswered questions","volume":"2","author":"Feinsod","year":"2026","journal-title":"Ferroptosis Oxid Stress"},{"key":"B59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: Principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111660","article-title":"Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomedicines"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.928321","article-title":"Ferroptosis in chronic liver diseases: Opportunities and challenges","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, biology, and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12915-025-02378-6","article-title":"Iron metabolism and ferroptosis in human health and disease","volume":"23","author":"Zhong","year":"2025","journal-title":"BMC Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101304","article-title":"Regulation of iron metabolism in ferroptosis: From mechanism research to clinical translation","volume":"15","author":"Zhang","year":"2025","journal-title":"J Pharm Anal"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000847","article-title":"Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network","volume":"9","author":"Sohal","year":"2025","journal-title":"Hepatol Commun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26238","article-title":"Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease","volume":"57","author":"Maliken","year":"2013","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202314710","article-title":"Strikingly high activity of 15-lipoxygenase towards di-polyunsaturated arachidonoyl\/adrenoyl-phosphatidylethanolamines generates peroxidation signals of ferroptotic cell death","volume":"63","author":"Samovich","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2026.1742305","article-title":"Lipid remodeling and ferroptosis in phosphatidylcholine-mediated tumor\u2013stroma crosstalk","volume":"13","author":"Vani Raju","year":"2026","journal-title":"Front Mol Biosci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","article-title":"Ferroptosis: An iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy","volume":"24","author":"Li","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s42003-024-07180-8","article-title":"Ferroptosis as a new tool for tumor suppression through lipid peroxidation","volume":"7","author":"Yang","year":"2024","journal-title":"Commun Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20212433","article-title":"Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells","volume":"42","author":"Kuwata","year":"2022","journal-title":"Biosci Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14740\/gr2098","article-title":"Acyl-CoA synthetase long-chain family member 4 in liver injury: Multidimensional regulation and therapeutic potential","volume":"19","author":"Liang","year":"2026","journal-title":"Gastroenterol Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates non-alcoholic steatohepatitis in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000684","article-title":"The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD","volume":"9","author":"Angendohr","year":"2025","journal-title":"Hepatol Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/biology10030184","article-title":"Lipid metabolism and ferroptosis","volume":"10","author":"Lee","year":"2021","journal-title":"Biology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006828117","article-title":"Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer","volume":"117","author":"Lee","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06328","article-title":"Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport","volume":"4","author":"Hashidate-Yoshida","year":"2015","journal-title":"eLife"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094836","article-title":"Hepatocyte-specific Fads1 overexpression attenuates Western diet-induced metabolic phenotypes in a rat model","volume":"25","author":"Ghooray","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14010012","article-title":"Lipid metabolism in metabolic-associated steatotic liver disease (MASLD)","volume":"14","author":"Syed-Abdul","year":"2023","journal-title":"Metabolites"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf346","article-title":"Metabolic dysfunction-associated steatotic liver disease alters fatty acid profiles in the liver and adipose tissue","volume":"111","author":"Palomurto","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.7150\/jca.71619","article-title":"Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer","volume":"13","author":"Shao","year":"2022","journal-title":"J Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"S2090-1232(26)0","DOI":"10.1016\/j.jare.2026.04.018","article-title":"LPCAT3 deficiency drives phospholipid remodeling and mitochondrial oxidative dysfunction to accelerate MASH-HCC development","author":"Shao","year":"2026","journal-title":"J Adv Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00769-0","article-title":"Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis","volume":"28","author":"Cui","year":"2021","journal-title":"Cell Death Differ"},{"key":"B88","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12964-024-01862-w","article-title":"Peroxisomal homeostasis in metabolic diseases and its implication in ferroptosis","volume":"22","author":"Han","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2021.02.005","article-title":"Peroxisomes as cellular adaptors to metabolic and environmental stress","volume":"31","author":"He","year":"2021","journal-title":"Trends Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29039","article-title":"Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis","volume":"66","author":"Jang","year":"2017","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.3390\/ijms26178303","article-title":"Peroxisome dysfunction and steatotic liver disease","volume":"26","author":"Vinoy","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06983-9","article-title":"7-Dehydrocholesterol dictates ferroptosis sensitivity","volume":"626","author":"Li","year":"2024","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06878-9","article-title":"7-Dehydrocholesterol is an endogenous suppressor of ferroptosis","volume":"626","author":"Freitas","year":"2024","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/s41467-024-46386-6","article-title":"Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis","volume":"15","author":"Yamada","year":"2024","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B96","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","article-title":"Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation\u2013mediated cell death in mice","volume":"190","author":"Qi","year":"2020","journal-title":"Am J Pathol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00770","article-title":"NADPH oxidases: From molecular mechanisms to current inhibitors","volume":"66","author":"Cipriano","year":"2023","journal-title":"J Med Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060890","article-title":"NADPH oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology","volume":"10","author":"Vermot","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.08.013","article-title":"Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production","volume":"45","author":"Dikalov","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2021.1881393","article-title":"The oxidoreductases POR and CYB5R1 catalyze lipid peroxidation to execute ferroptosis","volume":"8","author":"Ai","year":"2021","journal-title":"Mol Cell Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110661","article-title":"Ferroptosis in diabetic cardiomyopathy and atherosclerosis: Mechanisms and clinical prospects","volume":"26","author":"Huang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02300-5","article-title":"Ferroptosis: Biology and role in liver disease","volume":"60","author":"Hino","year":"2025","journal-title":"J Gastroenterol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: Molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15050287","article-title":"From childhood obesity to metabolic dysfunction-associated steatotic liver disease (MASLD) and hyperlipidemia through oxidative stress during childhood","volume":"15","author":"Accacha","year":"2025","journal-title":"Metabolites"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front Physiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162533","article-title":"Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity","author":"Greatorex","year":"134","journal-title":"J Clin Invest"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/metabo16070489","article-title":"Mitochondrial dysfunction in metabolic-syndrome-related MASLD\/MASH: Metabolic mechanisms and therapeutic perspectives","volume":"16","author":"Jin","year":"2026","journal-title":"Metabolites"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186420","article-title":"MASH: The nexus of metabolism, inflammation, and fibrosis","author":"Steinberg","year":"135","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.02.003","article-title":"A time to build and a time to burn: Glucose metabolism for every season","volume":"81","author":"McKean","year":"2021","journal-title":"Mol Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00752-w","article-title":"Regulation of and challenges in targeting NAD+ metabolism","volume":"25","author":"Migaud","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00415-0","article-title":"The assembly, regulation and function of the mitochondrial respiratory chain","volume":"23","author":"Vercellino","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00506-6","article-title":"Mechanisms of mitochondrial respiratory adaptation","volume":"23","author":"Bennett","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","article-title":"Mitochondrial metabolic reprogramming in diabetic kidney disease","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2026.117729","article-title":"Sustained cadmium exposure and hyperglycemia additively drives mitochondrial dysfunction in hepatic cells: Implications for MASLD etiopathogenesis","volume":"508","author":"Kumar","year":"2026","journal-title":"Toxicol Appl Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2026.1803228","article-title":"Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease","volume":"17","author":"Zuo","year":"2026","journal-title":"Front Physiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101774","article-title":"Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Mu","year":"2025","journal-title":"Ann Hepatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70141","article-title":"Unveiling the crucial nexus: Mitochondrial quality control as a central driver in metabolic dysfunction\u2010associated steatotic liver disease pathogenesis","volume":"59","author":"Fu","year":"2026","journal-title":"Cell Proliferation"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2023.100077","article-title":"Homeostasis of carbohydrates and reactive oxygen species is critically changed in the brain of middle-aged mice: Molecular mechanisms and functional reasons","volume":"3","author":"Bayliak","year":"2023","journal-title":"BBA Adv"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4103\/1673-5374.358614","article-title":"Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration","volume":"18","author":"Villal\u00f3n-Garc\u00eda","year":"2023","journal-title":"Neural Regener Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/inorganics10030031","article-title":"Mitochondrial de novo assembly of iron\u2013sulfur clusters in mammals: Complex matters in a complex that matters","volume":"10","author":"Perfitt","year":"2022","journal-title":"Inorganics"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00775-018-1548-6","article-title":"Iron\u2013sulfur clusters: From metals through mitochondria biogenesis to disease","volume":"23","author":"Cardenas-Rodriguez","year":"2018","journal-title":"J Biol Inorg Chem"},{"key":"B126","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.98183","article-title":"Lipid peroxidation as a link between unhealthy diets and the metabolic syndrome","volume-title":"Accenting Lipid Peroxidation","author":"Onyango","year":"2021"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170966","article-title":"Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress","volume":"38","author":"Schmitz-Peiffer","year":"2018","journal-title":"Biosci Rep"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040856","article-title":"The 4-hydroxynonenal\u2013protein adducts and their biological relevance: Are some proteins preferred targets","volume":"12","author":"Milkovic","year":"2023","journal-title":"Antioxidants"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157328","article-title":"Are hippocampal hypoperfusion and ATP depletion prime movers in the genesis of Alzheimer\u2019s disease? A review of recent pertinent observations from molecular biology","volume":"26","author":"Walker","year":"2025","journal-title":"IJMS"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physiol.00029.2023","article-title":"Membrane dynamics and cation handling in ferroptosis","volume":"39","author":"Hirata","year":"2024","journal-title":"Physiology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00691-x","article-title":"Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics","volume":"28","author":"Pedrera","year":"2021","journal-title":"Cell Death Differ"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2024.102966","article-title":"Calcium signals as regulators of ferroptosis in cancer","volume":"124","author":"Stejerean-Todoran","year":"2024","journal-title":"Cell Calcium"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15050618","article-title":"Regulation of ferroptosis sensitivity in hepatocellular carcinoma cells by lysosomal ion channels TPC2 and TRPML1","volume":"15","author":"Geisslinger","year":"2026","journal-title":"Antioxidants"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00055-y","article-title":"NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis","volume":"43","author":"Ramos","year":"2024","journal-title":"EMBO J"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1879836","article-title":"Calcium imbalance drives organelle network collapse and immune remodeling: Novel pathogenic mechanisms in MASLD progression","volume":"17","author":"Xu","year":"2026","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01315-4","article-title":"Knockdown of hepatic mitochondrial calcium uniporter mitigates MASH and fibrosis in mice","volume":"14","author":"Li","year":"2024","journal-title":"Cell Biosci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116553","article-title":"Perfluorooctane sulfonate induces ferroptosis-dependent non-alcoholic steatohepatitis via autophagy-MCU-caused mitochondrial calcium overload and MCU-ACSL4 interaction","volume":"280","author":"Ren","year":"2024","journal-title":"Ecotoxicology Environ Saf"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.158135","article-title":"Amygdalin alleviates MAFLD via inhibiting cytoplasmic calcium ion overload-induced liver sinusoidal endothelial cell defenestration","volume":"155","author":"Wang","year":"2026","journal-title":"Phytomedicine"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102695","article-title":"Mechanosensitive calcium ion channels Piezo1: A therapeutic target in liver disease","volume":"36","author":"Liu","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"B141","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.jpha.2024.03.001","article-title":"Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design","volume":"14","author":"Zhang","year":"2024","journal-title":"J Pharm Anal"},{"key":"B142","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12964-025-02447-x","article-title":"SLC7A11 as a bridge between ferroptosis and disulfidptosis: A promising target for tumor treatment","volume":"23","author":"Qiu","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B143","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","article-title":"Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration","volume":"9","author":"Carlson","year":"2016","journal-title":"Redox Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88949","article-title":"Efficacy and safety of vitamin E in adults with metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Hussaini","year":"2025","journal-title":"Cureus"},{"key":"B146","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12944-023-01855-7","article-title":"Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis","volume":"22","author":"Yuan","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1042\/CS20242825","article-title":"Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: A focus on diabetes and therapeutics","volume":"139","author":"Lee","year":"2025","journal-title":"Clin Sci (Lond)"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00023","article-title":"Heme oxygenase dependent bilirubin generation in vascular cells: A role in preventing endothelial dysfunction in local tissue microenvironment","volume":"11","author":"Nitti","year":"2020","journal-title":"Front Physiol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1039\/D5TB02738A","article-title":"Advances in Fenton reaction-mediated ferroptosis for enhanced cancer therapy: Mechanisms, amplification strategies, and synergistic approaches","volume":"14","author":"Huang","year":"2026","journal-title":"J Mater Chem B"},{"key":"B150","article-title":"Iron and magnetic: New research direction of the ferroptosis-based cancer therapy","volume":"8","author":"Wang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10565-026-10150-x","article-title":"Ferritinophagy: molecular mechanisms and its crosstalk with ferroptosis in chronic respiratory diseases","volume":"42","author":"Ning","year":"2026","journal-title":"Cell Biol Toxicol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12943-025-02520-6","article-title":"Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects","volume":"24","author":"Wu","year":"2025","journal-title":"Mol Cancer"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1615197","article-title":"Ferroptosis and bone metabolic diseases: the dual regulatory role of the Nrf2\/HO-1 signaling axis","volume":"13","author":"Nan","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70661","article-title":"Heme oxygenase-1 regulates the JAK\/STAT pathway to inhibit ferroptosis in metabolic dysfunction-associated steatotic liver disease","volume":"40","author":"Yao","year":"2026","journal-title":"J Biochem Mol Toxicol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122728","article-title":"EChinacoside alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis via Nrf2\/HMOX1 pathway","volume":"12","author":"Yan","year":"2024","journal-title":"Biomedicines"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103551","article-title":"Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside","volume":"81","author":"Dong","year":"2025","journal-title":"Redox Biol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13918","article-title":"Heme oxygenase-1 prevents non-alcoholic steatohepatitis through modulating mitochondrial quality control","volume":"237","author":"Li","year":"2023","journal-title":"Acta Physiol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104983","article-title":"Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1\/Notch1 pathway in myeloid cells","volume":"25","author":"Canesin","year":"2022","journal-title":"iScience"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2024.09.019","article-title":"Essentiality of SLC7A11-mediated nonessential amino acids in MASLD","volume":"69","author":"Shen","year":"2024","journal-title":"Sci Bull"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00096.2025","article-title":"Role of long chain acyl-CoA synthetases in MASH-driven hepatocellular carcinoma and ferroptosis","volume":"329","author":"Classon","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2026.01.007","article-title":"Targeting ferroptosis to halt MASLD and MASH","volume":"37","author":"Wang","year":"2026","journal-title":"Trends Endocrinol Metab"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2025.037","article-title":"Melatonin prevents the progression of MASLD via inhibiting FFAs-induced ferroptosis through KEAP1\/NRF2\/HO-1 pathway","volume":"33","author":"Li","year":"2025","journal-title":"Biomol Ther (Seoul)"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1172\/JCI196374","article-title":"Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production","volume":"136","author":"Jo","year":"2026","journal-title":"J Clin Invest"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01672-1","article-title":"Molecular mechanisms of ferroptosis and relevance to inflammation","volume":"72","author":"Deng","year":"2023","journal-title":"Inflammation Res"},{"key":"B165","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S478413","article-title":"Multi-omics exploration of the role of PTGS2 as a hub gene in ferroptosis within the artery of Takayasu arteritis","volume":"17","author":"Gao","year":"2024","journal-title":"J Inflammation Res"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152406","article-title":"Analysis and verification of potential ferroptosis-related diagnostic markers in the early stage of metabolic dysfunction-associated steatohepatitis","volume":"779","author":"Li","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B168","doi-asserted-by":"publisher","first-page":"19785","DOI":"10.1038\/s41598-019-56235-y","article-title":"FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis","volume":"9","author":"Coilly","year":"2019","journal-title":"Sci Rep"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182322","article-title":"Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver\u2013induced hepatocellular carcinoma by driving ITGB1-mediated \u03b2-catenin activation","volume":"135","author":"Leung","year":"2025","journal-title":"J Clin Invest"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000484","article-title":"Gut microbial metabolites in MASLD: implications of mitochondrial dysfunction in the pathogenesis and treatment","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol Commun"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147702","article-title":"Mitochondria matter: systemic aspects of nonalcoholic fatty liver disease (NAFLD) and diagnostic assessment of liver function by stable isotope dynamic breath tests","volume":"22","author":"Di Ciaula","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.26.23293038","article-title":"A novel gene-screening approach reveals QSOX1\/IL1RAP as promising biomarkers for the severity of non-alcoholic fatty liver disease","author":"Ma","year":"2023","journal-title":"medRxiv"},{"key":"B173","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s40001-023-01457-0","article-title":"Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease","volume":"28","author":"Zhang","year":"2023","journal-title":"Eur J Med Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s12672-025-04062-1","article-title":"Targeting ferroptosis by noncoding RNAs as a novel therapeutic strategy for hepatocellular carcinoma","volume":"16","author":"Mohammadi","year":"2025","journal-title":"Discov Oncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9613095","article-title":"Downregulation of HULC induces ferroptosis in hepatocellular carcinoma via targeting of the miR-3200-5p\/ATF4 axis","volume":"2022","author":"Guan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B176","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13062-024-00530-w","article-title":"Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma","volume":"19","author":"Sun","year":"2024","journal-title":"Biol Direct"},{"key":"B177","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12935-024-03559-z","article-title":"Ferroptosis: insight into the treatment of hepatocellular carcinoma","volume":"24","author":"Liao","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13050719","article-title":"Modulation of ferroptosis by microRNAs in human cancer","volume":"13","author":"Velkova","year":"2023","journal-title":"J Pers Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.05.007","article-title":"Non-coding RNA: a key regulator in the Glutathione-GPX4 pathway of ferroptosis","volume":"9","author":"Hussain","year":"2024","journal-title":"Non-coding RNA Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1517401","article-title":"The role of ferroptosis-related non-coding RNA in liver fibrosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10238-025-01766-0","article-title":"MicroRNAs at the crossroads of exercise and ferroptosis: a regulatory bridge","volume":"25","author":"Lin","year":"2025","journal-title":"Clin Exp Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713336","article-title":"The regulation of ferroptosis by noncoding RNAs","volume":"24","author":"Zheng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2023.2166483","article-title":"miR-761-hepcidin\/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis","volume":"39","author":"Zheng","year":"2023","journal-title":"Gynecological Endocrinol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29496","article-title":"MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells","volume":"235","author":"Bai","year":"2020","journal-title":"J Cell Physiol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-023-01608-6","article-title":"Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation","volume":"9","author":"Luo","year":"2023","journal-title":"Cell Death Discov"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2022.102271","article-title":"MiR-129-3p regulates ferroptosis in the liver of selenium-deficient broilers by targeting SLC7A11","volume":"102","author":"Zhang","year":"2022","journal-title":"Poult Sci"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.01.090","article-title":"The release and activity of HMGB1 in ferroptosis","volume":"510","author":"Wen","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J Clin Invest"},{"key":"B191","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cmet.2019.10.014","article-title":"Neutralization of oxidized phospholipids ameliorates non-alcoholic steatohepatitis","volume":"31","author":"Sun","year":"2020","journal-title":"Cell Metab"},{"key":"B192","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2017.01.012","article-title":"Metabolic zonation of the liver: the oxygen gradient revisited","volume":"11","author":"Kietzmann","year":"2017","journal-title":"Redox Biol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217703978","article-title":"Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems","volume":"242","author":"Lee-Montiel","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32408","article-title":"Liver zonation, revisited","volume":"76","author":"Paris","year":"2022","journal-title":"Hepatology"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/nature21065","article-title":"Single-cell spatial reconstruction reveals global division of labor in the mammalian liver","volume":"542","author":"Halpern","year":"2017","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.3390\/ijms262110701","article-title":"Hepatic zonation in MASLD: old question, new challenge in the era of spatial omics","volume":"26","author":"Paolini","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B198","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1038\/s41598-018-27179-6","article-title":"Metabolic patterning on a chip: towards in vitro liver zonation of primary rat and human hepatocytes","volume":"8","author":"Kang","year":"2018","journal-title":"Sci Rep"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28953","article-title":"Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease","volume":"65","author":"Hall","year":"2017","journal-title":"Hepatology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158462","article-title":"NAFLD (MASLD)\/NASH (MASH): does it bother to label at all? A comprehensive narrative review","volume":"25","author":"Sergi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241276334","article-title":"Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques","volume":"17","author":"Hudson","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1431652","article-title":"Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding","volume":"15","author":"Yu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010151","article-title":"The role of Kupffer cells and liver macrophages in the pathogenesis of metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Tsomidis","year":"2026","journal-title":"Biomedicines"},{"key":"B204","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10565-025-10111-w","article-title":"Ferroptosis in liver fibrosis and its potential intervention strategy","volume":"41","author":"Zhu","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2026.101099","article-title":"Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities","volume":"7","author":"Zhou","year":"2026","journal-title":"Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578401","article-title":"HMGB1\/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome","volume":"393","author":"Lei","year":"2024","journal-title":"J Neuroimmunol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1600596","article-title":"Involvement of role of HMGB1-NLRP3 pathway in systemic disorders","volume":"13","author":"Yang","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial ROS induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1111\/all.16236","article-title":"Pyroptosis, Gasdermins and allergic diseases","volume":"79","author":"Panganiban","year":"2024","journal-title":"Allergy"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091364","article-title":"The multiple facets of iron recycling","volume":"12","author":"Slusarczyk","year":"2021","journal-title":"Genes (Basel)"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050861","article-title":"Crosstalk between heme oxygenase-1 and iron metabolism in macrophages: implications for the modulation of inflammation and immunity","volume":"11","author":"de Oliveira","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-03620-9","article-title":"The serum hepcidin and the hepcidin\/ferritin ratio in NAFLD: a systematic review and meta-analysis","volume":"25","author":"Song","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat Chem Biol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049114","article-title":"Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis","volume":"51","author":"Piattini","year":"2021","journal-title":"Eur J Immunol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203973","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102244","article-title":"Playing Jekyll and Hyde\u2014The dual role of lipids in fatty liver disease","volume":"9","author":"Molenaar","year":"2020","journal-title":"Cells"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00548","article-title":"Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: Is it the dawning of a new era","volume":"11","author":"Chan","year":"2020","journal-title":"Front Pharmacol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.043","article-title":"GARP on hepatic stellate cells is essential for the development of liver fibrosis","volume":"79","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64300-3","article-title":"Identification and characterization of the hepatic stellate cell transferrin receptor","volume":"162","author":"Bridle","year":"2003","journal-title":"Am J Pathol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1258870","article-title":"Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis","volume":"10","author":"Tang","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01068-6","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"2020","journal-title":"Autophagy"},{"key":"B229","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/iub.1895","article-title":"P53\u2010dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride\u2010induced liver fibrosis and hepatic stellate cell activation","volume":"71","author":"Wang","year":"2019","journal-title":"IUBMB Life"},{"key":"B230","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41419-020-2732-5","article-title":"The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope","volume":"11","author":"Mao","year":"2020","journal-title":"Cell Death Dis"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15050552","article-title":"Pirfenidone sensitizes hepatic stellate cells to ferroptosis by reprogramming glutamine and serine metabolism for GSH depletion","volume":"15","author":"Li","year":"2026","journal-title":"Antioxidants"},{"key":"B232","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41419-026-08898-5","article-title":"Carvedilol triggers ferroptosis in hepatic stellate cells via the ATF4\/SAT1 axis promoting spermidine depletion to ameliorate liver fibrosis","volume":"17","author":"Xia","year":"2026","journal-title":"Cell Death Dis"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-026-01740-0","article-title":"DN203316, a novel PPAR\u03b4 agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis","volume":"58","author":"Kim","year":"2026","journal-title":"Exp Mol Med"},{"key":"B234","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12964-026-02997-8","article-title":"Liver sinusoidal endothelial cell fenestrations in metabolic liver disease: from molecular mechanisms to therapeutic perspectives","volume":"24","author":"Al-Mughalles","year":"2026","journal-title":"Cell Commun Signal"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26168006","article-title":"Liver sinusoidal endothelial cells and their regulation of immunology, collagenization, and bioreactivity in fatty liver: a narrative review","volume":"26","author":"Abdulmajeed","year":"2025","journal-title":"IJMS"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174354","article-title":"Cold stress\u2013induced ferroptosis in liver sinusoidal endothelial cells determines liver transplant injury and outcomes","volume":"9","author":"Kojima","year":"2024","journal-title":"JCI Insight"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.12.002","article-title":"EMP1-driven ferroptosis in liver sinusoidal endothelial cells exacerbates hepatic ischemia-reperfusion injury via P38 MAPK","volume":"244","author":"Yang","year":"2026","journal-title":"Free Radical Biol Med"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140857","article-title":"T cell lipid peroxidation induces ferroptosis and prevents immunity to infection","volume":"212","author":"Matsushita","year":"2015","journal-title":"J Exp Med"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2026.04.010","article-title":"Tim-3 facilitates dendritic cell ferroptosis and impairs antitumor immunity in steatohepatitis-related HCC","volume":"85","author":"Li","year":"2026","journal-title":"J Hepatol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1825015","article-title":"CD36 aggravates ferroptosis in NK cells and dampens their anti-fibrotic activity in the liver","volume":"17","author":"Shen","year":"2026","journal-title":"Front Immunol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00843-2","article-title":"Recommendations for robust and reproducible research on ferroptosis","volume":"26","author":"Mishima","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146672","article-title":"Exploring recent developments in the manifestation, diagnosis, and treatment of patients with Smith\u2013Lemli\u2013Opitz syndrome: from molecular pathways to clinical innovations","volume":"26","author":"\u017bukowska","year":"2025","journal-title":"IJMS"},{"key":"B246","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acs.chemrestox.6b00054","article-title":"Inhibitors of 7-dehydrocholesterol reductase: screening of a collection of pharmacologically active compounds in Neuro2a cells","volume":"29","author":"Kim","year":"2016","journal-title":"Chem Res Toxicol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1912709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:30:40Z","timestamp":1789651840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1912709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":246,"alternative-id":["10.3389\/fimmu.2026.1912709"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1912709","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1912709"}}